Glossary of virology: Difference between revisions
From WikiMD's Wellness Encyclopedia
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
This '''glossary of virology''' is a list of definitions of terms and concepts used in the study of [[virology]], particularly in the description of [[virus]]es and their actions. | This '''glossary of virology''' is a list of definitions of terms and concepts used in the study of [[virology]], particularly in the description of [[virus]]es and their actions. | ||
{{compact ToC|side=yes|center=yes|nobreak=yes|seealso=yes|refs=yes|f=|j=|w=|x=|y=}} | {{compact ToC|side=yes|center=yes|nobreak=yes|seealso=yes|refs=yes|f=|j=|w=|x=|y=}} | ||
== Glossary of Virology == | == Glossary of Virology == | ||
* '''[[AHL-1 cells]]''' – A human cell line used in virology studies, particularly for hepatitis and oncogenic virus research. | * '''[[AHL-1 cells]]''' – A human cell line used in virology studies, particularly for hepatitis and oncogenic virus research. | ||
* '''[[Accessory gene regulator]]''' – A quorum sensing system in some bacteria and viruses that modulates gene expression, particularly in pathogenesis. | * '''[[Accessory gene regulator]]''' – A quorum sensing system in some bacteria and viruses that modulates gene expression, particularly in pathogenesis. | ||
* '''[[Antigenic drift]]''' – A process of gradual accumulation of mutations in viral [[antigens]], leading to changes in viral surface proteins and reduced immune recognition. | * '''[[Antigenic drift]]''' – A process of gradual accumulation of mutations in viral [[antigens]], leading to changes in viral surface proteins and reduced immune recognition. | ||
* '''[[Antigenic shift]]''' – A sudden, major change in a virus’s genome, especially in [[influenza viruses]], resulting in a novel [[subtype]] to which most humans lack immunity. | * '''[[Antigenic shift]]''' – A sudden, major change in a virus’s genome, especially in [[influenza viruses]], resulting in a novel [[subtype]] to which most humans lack immunity. | ||
* '''[[Attenuated vaccine]]''' – A vaccine created using a weakened form of a virus that is still capable of replication but not causing disease. | * '''[[Attenuated vaccine]]''' – A vaccine created using a weakened form of a virus that is still capable of replication but not causing disease. | ||
* '''[[Autogenous vaccines]]''' – Vaccines made from pathogens isolated from the same individual or herd for targeted treatment. | * '''[[Autogenous vaccines]]''' – Vaccines made from pathogens isolated from the same individual or herd for targeted treatment. | ||
* '''[[Autoinoculation]]''' – The process by which an individual spreads a viral infection to different parts of their body. | * '''[[Autoinoculation]]''' – The process by which an individual spreads a viral infection to different parts of their body. | ||
* '''[[B type inclusion]]''' – Cytoplasmic inclusion bodies often found in cells infected with poxviruses. | * '''[[B type inclusion]]''' – Cytoplasmic inclusion bodies often found in cells infected with poxviruses. | ||
* '''[[BCP-1 cells]]''' – A human B-cell line used in studies of [[Kaposi’s sarcoma-associated herpesvirus]] and other gammaherpesviruses. | * '''[[BCP-1 cells]]''' – A human B-cell line used in studies of [[Kaposi’s sarcoma-associated herpesvirus]] and other gammaherpesviruses. | ||
* '''[[Baby hamster kidney cell]]''' – A widely used mammalian cell line (BHK-21) for culturing [[animal viruses]] and vaccine production. | * '''[[Baby hamster kidney cell]]''' – A widely used mammalian cell line (BHK-21) for culturing [[animal viruses]] and vaccine production. | ||
* '''[[Baltimore classification]]''' – A system that classifies [[viruses]] based on their type of genome (DNA or RNA, single- or double-stranded) and replication strategy. | * '''[[Baltimore classification]]''' – A system that classifies [[viruses]] based on their type of genome (DNA or RNA, single- or double-stranded) and replication strategy. | ||
* '''[[Branched DNA assay]]''' – A signal amplification nucleic acid test used for detecting and quantifying viral RNA or DNA. | * '''[[Branched DNA assay]]''' – A signal amplification nucleic acid test used for detecting and quantifying viral RNA or DNA. | ||
* '''[[Cap snatching]]''' – A mechanism used by some RNA viruses to "steal" 5’ caps from host mRNAs to initiate viral mRNA synthesis. | * '''[[Cap snatching]]''' – A mechanism used by some RNA viruses to "steal" 5’ caps from host mRNAs to initiate viral mRNA synthesis. | ||
* '''[[Capsid]]''' – The protein shell of a virus that encloses its genetic material. | * '''[[Capsid]]''' – The protein shell of a virus that encloses its genetic material. | ||
* '''[[Capsomere]]''' – The subunit of a [[capsid]], formed by protein molecules. | * '''[[Capsomere]]''' – The subunit of a [[capsid]], formed by protein molecules. | ||
* '''[[Cell-based vaccine]]''' – A type of vaccine developed using cultured cells instead of fertilized chicken eggs, commonly used for [[influenza]]. | * '''[[Cell-based vaccine]]''' – A type of vaccine developed using cultured cells instead of fertilized chicken eggs, commonly used for [[influenza]]. | ||
* '''[[Coinfection]]''' – The simultaneous infection of a host by two or more virus strains or different pathogens. | * '''[[Coinfection]]''' – The simultaneous infection of a host by two or more virus strains or different pathogens. | ||
* '''[[Common Cold Unit]]''' – A former UK-based research facility dedicated to studying respiratory viruses, especially the [[common cold]]. | * '''[[Common Cold Unit]]''' – A former UK-based research facility dedicated to studying respiratory viruses, especially the [[common cold]]. | ||
* '''[[Cryspovirus]]''' – A genus of viruses that infect [[protozoa]] like Cryptosporidium. | * '''[[Cryspovirus]]''' – A genus of viruses that infect [[protozoa]] like Cryptosporidium. | ||
* '''[[DNA vaccine]]''' – A vaccine that uses a plasmid containing viral DNA to elicit an immune response. | * '''[[DNA vaccine]]''' – A vaccine that uses a plasmid containing viral DNA to elicit an immune response. | ||
* '''[[DNA virus]]''' – A virus that has DNA as its genetic material and replicates using DNA-dependent DNA polymerase. | * '''[[DNA virus]]''' – A virus that has DNA as its genetic material and replicates using DNA-dependent DNA polymerase. | ||
* '''[[DPVweb]]''' – A curated database of [[plant viruses]] and their properties. | * '''[[DPVweb]]''' – A curated database of [[plant viruses]] and their properties. | ||
* '''[[Decoy cells]]''' – Cells in the urine resembling virally infected urothelial cells, typically associated with [[polyomavirus]] infection. | * '''[[Decoy cells]]''' – Cells in the urine resembling virally infected urothelial cells, typically associated with [[polyomavirus]] infection. | ||
* '''[[Duck embryo vaccine]]''' – A vaccine produced using [[duck embryos]], historically used for [[rabies]] and other zoonotic viruses. | * '''[[Duck embryo vaccine]]''' – A vaccine produced using [[duck embryos]], historically used for [[rabies]] and other zoonotic viruses. | ||
* '''[[Ecotropism]]''' – The tendency of certain viruses to infect only specific species or cell types. | * '''[[Ecotropism]]''' – The tendency of certain viruses to infect only specific species or cell types. | ||
* '''[[Embryonated]]''' – Refers to fertilized chicken eggs used to culture and propagate viruses, especially for vaccine production. | * '''[[Embryonated]]''' – Refers to fertilized chicken eggs used to culture and propagate viruses, especially for vaccine production. | ||
* '''[[Emergent virus]]''' – A newly identified virus that has recently appeared in a population or is rapidly increasing in incidence. | * '''[[Emergent virus]]''' – A newly identified virus that has recently appeared in a population or is rapidly increasing in incidence. | ||
* '''[[Endogenous viral element]]''' – Viral sequences that have integrated into the host genome over evolutionary time. | * '''[[Endogenous viral element]]''' – Viral sequences that have integrated into the host genome over evolutionary time. | ||
* '''[[Endothelial cell tropism]]''' – The preference of certain viruses to infect the endothelial cells lining blood vessels. | * '''[[Endothelial cell tropism]]''' – The preference of certain viruses to infect the endothelial cells lining blood vessels. | ||
* '''[[GISAID]]''' – The Global Initiative on Sharing All Influenza Data, a platform for sharing genome sequences of flu and emerging viruses like [[SARS-CoV-2]]. | * '''[[GISAID]]''' – The Global Initiative on Sharing All Influenza Data, a platform for sharing genome sequences of flu and emerging viruses like [[SARS-CoV-2]]. | ||
* '''[[Gain-of-function research]]''' – Studies involving the enhancement of viral properties, such as transmissibility or pathogenicity, for scientific purposes. | * '''[[Gain-of-function research]]''' – Studies involving the enhancement of viral properties, such as transmissibility or pathogenicity, for scientific purposes. | ||
* '''[[Global Virome Project]]''' – A collaborative effort to discover and catalog unknown viruses with potential pandemic risk. | * '''[[Global Virome Project]]''' – A collaborative effort to discover and catalog unknown viruses with potential pandemic risk. | ||
* '''[[Global Virus Network (GVN)]]''' – A coalition of medical virologists working to prevent and control viral diseases through global research. | * '''[[Global Virus Network (GVN)]]''' – A coalition of medical virologists working to prevent and control viral diseases through global research. | ||
* '''[[Glossary of virology]]''' – A compiled list of terms and definitions commonly used in the field of [[virology]]. | * '''[[Glossary of virology]]''' – A compiled list of terms and definitions commonly used in the field of [[virology]]. | ||
* '''[[Group-specific antigen]]''' – Viral antigens specific to a group of viruses, used for diagnosis or vaccine design. | * '''[[Group-specific antigen]]''' – Viral antigens specific to a group of viruses, used for diagnosis or vaccine design. | ||
* '''[[HIV capsid inhibition]]''' – A therapeutic strategy that targets the capsid protein of [[HIV]] to inhibit viral replication. | * '''[[HIV capsid inhibition]]''' – A therapeutic strategy that targets the capsid protein of [[HIV]] to inhibit viral replication. | ||
* '''[[HIV latency]]''' – The ability of [[Human Immunodeficiency Virus (HIV)]] to remain dormant in host cells, forming a major barrier to a cure. | * '''[[HIV latency]]''' – The ability of [[Human Immunodeficiency Virus (HIV)]] to remain dormant in host cells, forming a major barrier to a cure. | ||
* '''[[Helper dependent virus]]''' – A virus that requires the presence of a [[helper virus]] to replicate. | * '''[[Helper dependent virus]]''' – A virus that requires the presence of a [[helper virus]] to replicate. | ||
* '''[[Helper virus]]''' – A virus that assists another defective or satellite virus to complete its replication cycle. | * '''[[Helper virus]]''' – A virus that assists another defective or satellite virus to complete its replication cycle. | ||
* '''[[Heterophile antibody test]]''' – A diagnostic test for [[Epstein-Barr virus]] using cross-reactive antibodies. | * '''[[Heterophile antibody test]]''' – A diagnostic test for [[Epstein-Barr virus]] using cross-reactive antibodies. | ||
* '''[[Host tropism]]''' – The specificity of a virus for infecting particular host species or cell types. | * '''[[Host tropism]]''' – The specificity of a virus for infecting particular host species or cell types. | ||
* '''[[Human Immunodeficiency Virus (HIV)]]''' – A retrovirus that causes [[AIDS]] by targeting [[CD4+ T cells]] in the human immune system. | * '''[[Human Immunodeficiency Virus (HIV)]]''' – A retrovirus that causes [[AIDS]] by targeting [[CD4+ T cells]] in the human immune system. | ||
* '''[[Inclusion bodies]]''' – Intracellular structures formed during viral replication, often used as markers of infection. | * '''[[Inclusion bodies]]''' – Intracellular structures formed during viral replication, often used as markers of infection. | ||
* '''[[Integrase]]''' – A viral enzyme used by [[retroviruses]] to insert their genome into the host DNA. | * '''[[Integrase]]''' – A viral enzyme used by [[retroviruses]] to insert their genome into the host DNA. | ||
* '''[[Intrastructural help]]''' – An immunological phenomenon where preexisting immunity to one viral protein enhances responses to others. | * '''[[Intrastructural help]]''' – An immunological phenomenon where preexisting immunity to one viral protein enhances responses to others. | ||
* '''[[Intrinsic immunity]]''' – Innate defense mechanisms in host cells that restrict viral replication even before adaptive immune responses. | * '''[[Intrinsic immunity]]''' – Innate defense mechanisms in host cells that restrict viral replication even before adaptive immune responses. | ||
* '''[[Laboratory-acquired infection]]''' – Infections contracted by lab personnel due to accidental exposure to infectious viruses. | * '''[[Laboratory-acquired infection]]''' – Infections contracted by lab personnel due to accidental exposure to infectious viruses. | ||
* '''[[Leaky scanning]]''' – A translational control mechanism where ribosomes bypass the first start codon and initiate translation downstream. | * '''[[Leaky scanning]]''' – A translational control mechanism where ribosomes bypass the first start codon and initiate translation downstream. | ||
* '''[[Live virus reference strain]]''' – A well-characterized virus used as a standard in vaccine production or diagnostic testing. | * '''[[Live virus reference strain]]''' – A well-characterized virus used as a standard in vaccine production or diagnostic testing. | ||
* '''[[Lysogenic cycle]]''' – A viral life cycle in which the genome is integrated into the host cell’s DNA and replicates passively without immediate destruction. | * '''[[Lysogenic cycle]]''' – A viral life cycle in which the genome is integrated into the host cell’s DNA and replicates passively without immediate destruction. | ||
* '''[[Lytic cycle]]''' – A viral replication cycle that leads to the production of new viruses and host cell lysis. | * '''[[Lytic cycle]]''' – A viral replication cycle that leads to the production of new viruses and host cell lysis. | ||
* '''[[Multiplicity of infection]]''' – The ratio of infecting virus particles to target cells in an experimental setting. | * '''[[Multiplicity of infection]]''' – The ratio of infecting virus particles to target cells in an experimental setting. | ||
* '''[[Neurovirology]]''' – The study of viruses that affect the nervous system and their interactions with neural cells. | * '''[[Neurovirology]]''' – The study of viruses that affect the nervous system and their interactions with neural cells. | ||
* '''[[Nomenclature codes]]''' – Standardized rules used to name viruses and virus families as determined by bodies like the [[ICTV]]. | * '''[[Nomenclature codes]]''' – Standardized rules used to name viruses and virus families as determined by bodies like the [[ICTV]]. | ||
* '''[[Non-cellular life]]''' – Refers to entities like viruses and [[viroids]] that do not consist of cells but possess life-like properties. | * '''[[Non-cellular life]]''' – Refers to entities like viruses and [[viroids]] that do not consist of cells but possess life-like properties. | ||
* '''[[Oncovirus]]''' – A virus capable of causing [[cancer]] in humans or animals, e.g., [[HPV]] or [[EBV]]. | * '''[[Oncovirus]]''' – A virus capable of causing [[cancer]] in humans or animals, e.g., [[HPV]] or [[EBV]]. | ||
* '''[[Original antigenic sin]]''' – The immune system’s tendency to preferentially use memory responses from a first exposure even after exposure to a new strain. | * '''[[Original antigenic sin]]''' – The immune system’s tendency to preferentially use memory responses from a first exposure even after exposure to a new strain. | ||
* '''[[Orphan virus]]''' – A virus identified in the absence of a known associated disease. | * '''[[Orphan virus]]''' – A virus identified in the absence of a known associated disease. | ||
* '''[[Paleovirology]]''' – The study of ancient viruses and their interactions with hosts through the analysis of endogenous viral elements in genomes. | * '''[[Paleovirology]]''' – The study of ancient viruses and their interactions with hosts through the analysis of endogenous viral elements in genomes. | ||
* '''[[Passenger virus]]''' – A virus detected in a host without evidence of disease or replication. | * '''[[Passenger virus]]''' – A virus detected in a host without evidence of disease or replication. | ||
* '''[[Permissive cell]]''' – A host cell that allows complete replication of a virus. | * '''[[Permissive cell]]''' – A host cell that allows complete replication of a virus. | ||
* '''[[PhEVER]]''' – A database of viral and host evolutionary relationships. | * '''[[PhEVER]]''' – A database of viral and host evolutionary relationships. | ||
* '''[[PhagesDB]]''' – A database of bacteriophages and related data, commonly used in phage research. | * '''[[PhagesDB]]''' – A database of bacteriophages and related data, commonly used in phage research. | ||
* '''[[Phenotype mixing]]''' – A process where progeny viruses acquire proteins from a different parental virus without genetic recombination. | * '''[[Phenotype mixing]]''' – A process where progeny viruses acquire proteins from a different parental virus without genetic recombination. | ||
* '''[[Phycodnaviridae]]''' – A family of large dsDNA viruses that infect [[algae]]. | * '''[[Phycodnaviridae]]''' – A family of large dsDNA viruses that infect [[algae]]. | ||
* '''[[Plant virus]]''' – A virus that specifically infects plants, often spread by insect vectors or through mechanical means. | * '''[[Plant virus]]''' – A virus that specifically infects plants, often spread by insect vectors or through mechanical means. | ||
* '''[[Plaque-forming unit]]''' – A measure of infectious virus particles, defined as one infectious unit that forms a visible plaque on a cell monolayer. | * '''[[Plaque-forming unit]]''' – A measure of infectious virus particles, defined as one infectious unit that forms a visible plaque on a cell monolayer. | ||
* '''[[Pleomorphism (microbiology)]]''' – The variability in shape and size among virus particles of the same species. | * '''[[Pleomorphism (microbiology)]]''' – The variability in shape and size among virus particles of the same species. | ||
* '''[[Portal:Viruses]]''' – A central hub for accessing Wikipedia articles and resources related to [[virology]] and [[viruses]]. | |||
* '''[[Pre-integration complex]]''' – A nucleoprotein structure formed by retroviruses after entry, containing viral DNA and enzymes like [[integrase]] for integration into the host genome. | |||
* '''[[Prophage]]''' – A dormant form of a bacteriophage genome integrated into a [[bacterial]] chromosome during the [[lysogenic cycle]]. | |||
* '''[[Provirus]]''' – Viral DNA that is integrated into the genome of a host cell, particularly in the context of [[retroviruses]] like [[HIV]]. | |||
* '''[[Pseudodiploid]]''' – Describes cells (such as HIV particles) that carry two RNA genomes but replicate like diploids without true recombination. | |||
* '''[[Pseudotyping]]''' – The process of producing recombinant viral particles that bear surface proteins (envelope) from a different virus, used in gene therapy and vaccine development. | |||
* '''[[Q-number]]''' – A quality control identifier used in standardized virology tests and publications. | |||
* '''[[Quasispecies model]]''' – A concept describing viral populations as dynamic, highly diverse groups of mutants around a consensus sequence, particularly in RNA viruses. | |||
* '''[[RNA interference]]''' – A cellular defense mechanism that degrades viral RNA, used in research and therapy to silence gene expression. | |||
* '''[[RNA virus]]''' – A virus that uses RNA as its genetic material; includes positive-sense, negative-sense, and double-stranded RNA viruses. | |||
* '''[[Reassortment]]''' – The exchange of genome segments between different viral strains during coinfection, common in segmented RNA viruses like influenza. | |||
* '''[[Recombinant virus]]''' – A genetically engineered virus containing genes from multiple sources, used in vaccine design and gene therapy. | |||
* '''[[Reporter virus particles]]''' – Viruses modified to include a reporter gene, allowing detection of infection or replication by a visible signal. | |||
* '''[[Satellite (biology)]]''' – A subviral agent that requires a helper virus for replication, often dependent on the capsid proteins of the helper. | |||
* '''[[See virion]]''' – Refers to the complete infectious viral particle, see [[virion]]. | |||
* '''[[Sense (molecular biology)]]''' – Refers to the orientation of RNA in terms of its coding potential: [[positive-sense]] or [[negative-sense]] RNA. | |||
* '''[[Serial passage]]''' – A method of virus attenuation or adaptation by repeatedly infecting new hosts or cell cultures. | |||
* '''[[Serratus (virology)]]''' – A cloud-based platform for the ultra-fast alignment and classification of RNA viruses in metagenomic data. | |||
* '''[[Slow virus]]''' – A virus that causes disease after a prolonged incubation period, such as [[prions]] or [[lentiviruses]]. | |||
* '''[[Spike protein]]''' – A surface glycoprotein that mediates viral entry by binding to host cell receptors; a key target in [[SARS-CoV-2]] vaccine development. | |||
* '''[[Strain (biology)]]''' – A genetic variant or subtype of a virus, often with specific phenotypic characteristics. | |||
* '''[[Superinfection]]''' – Infection by a second virus in a host already infected with another, potentially altering disease outcome. | |||
* '''[[Szybalski's rule]]''' – A rule stating that in [[double-stranded DNA]], the non-template strand tends to be richer in guanine. | |||
* '''[[T-number]]''' – A value describing the complexity of icosahedral virus capsid symmetry in terms of triangular facets. | |||
* '''[[TRIM5alpha]]''' – A host protein that inhibits retroviral replication by blocking uncoating of the viral capsid. | |||
* '''[[Temperateness (virology)]]''' – Describes viruses capable of entering both [[lytic]] and [[lysogenic]] cycles. | |||
* '''[[The Last Days of Smallpox]]''' – A documentary about the final eradication efforts for [[smallpox]], a landmark in virological history. | |||
* '''[[Tissue tropism]]''' – The preference of a virus for infecting specific tissues or organs within a host. | |||
* '''[[Transduction (genetics)]]''' – The process by which foreign DNA is introduced into a cell by a [[bacteriophage]]. | |||
* '''[[Vaccine shedding]]''' – The release of vaccine virus from a vaccinated individual, usually associated with live attenuated vaccines. | |||
* '''[[Vaccine trial]]''' – A clinical study designed to evaluate the safety, efficacy, and immunogenicity of a vaccine candidate. | |||
* '''[[Vaccine]]''' – A preparation that stimulates the immune system to prevent disease, often containing inactivated or attenuated viruses. | |||
* '''[[Variant (biology)]]''' – A version of a virus with genetic differences from a reference strain, potentially altering transmissibility or immune response. | |||
* '''[[VirCapSeq]]''' – A high-throughput method for capturing and sequencing viral genomes from complex samples. | |||
* '''[[Viral culture]]''' – The process of growing viruses in cell lines or tissues to study replication, pathogenesis, or for vaccine production. | |||
* '''[[Viral dynamics]]''' – The quantitative study of how viruses replicate, spread, and interact with host immune responses over time. | |||
* '''[[Viral entry]]''' – The process by which viruses penetrate host cells, involving attachment, fusion, or endocytosis. | |||
* '''[[Viral envelope]]''' – A lipid bilayer derived from the host membrane, enclosing some viruses and aiding in host cell entry. | |||
* '''[[Viral epitranscriptome]]''' – Modifications to viral RNA that regulate its stability, translation, or interaction with host defenses. | |||
* '''[[Viral eukaryogenesis]]''' – The hypothesis that viruses may have played a role in the origin of the eukaryotic cell nucleus. | |||
* '''[[Viral evolution]]''' – The genetic changes in virus populations over time due to mutation, selection, recombination, and drift. | |||
* '''[[Viral interference]]''' – The phenomenon where one virus prevents the replication of another virus in the same host cell. | |||
* '''[[Viral load]]''' – The amount of viral RNA or DNA in a host's body, often used as a marker of infection severity. | |||
* '''[[Viral matrix protein]]''' – A structural protein located between the capsid and envelope, critical for viral assembly and budding. | |||
* '''[[Viral metagenomics]]''' – The study of viral diversity and abundance in environmental or clinical samples using genome sequencing. | |||
* '''[[Viral neuronal tracing]]''' – A method using viruses to map neural circuits by tracing connections between neurons. | |||
* '''[[Viral pathogenesis]]''' – The process by which viruses cause disease in a host organism. | |||
* '''[[Viral phylodynamics]]''' – The integration of viral evolution with epidemiological and immunological dynamics. | |||
* '''[[Viral plaque]]''' – A clear area on a cell monolayer caused by virus-induced cell lysis, used to quantify infectious virus particles. | |||
* '''[[Viral protein]]''' – Any protein encoded by a virus, often involved in replication, immune evasion, or structural integrity. | |||
* '''[[Viral quasispecies]]''' – A group of closely related viruses within a host that exist as a mutant cloud, typical of RNA viruses. | |||
* '''[[Viral replication]]''' – The process by which a virus reproduces inside a host cell, involving genome synthesis and particle assembly. | |||
* '''[[Viral shedding]]''' – The release of virus particles from an infected host through respiratory droplets, feces, or other means. | |||
* '''[[Viral synapse]]''' – A structured interface between infected and uninfected cells that facilitates efficient virus transfer. | |||
* '''[[Viral tegument]]''' – A protein layer between the capsid and envelope in [[herpesviruses]], involved in early infection steps. | |||
* '''[[Viral transformation]]''' – The process by which viruses cause permanent genetic changes in a host cell, potentially leading to [[oncogenesis]]. | |||
* '''[[ViralZone]]''' – An online database offering curated information on viral families, structure, replication, and classification. | |||
* '''[[Viremia]]''' – The presence of viruses in the bloodstream, an indicator of systemic infection. | |||
* '''[[Virion]]''' – The complete, infectious form of a virus, consisting of the genome, [[capsid]], and, in some cases, an envelope. | |||
* '''[[Viroinformatics]]''' – The application of bioinformatics tools to virology, including genome annotation and vaccine design. | |||
* '''[[Virokine]]''' – A viral protein that mimics host cytokines, used by viruses to modulate the immune system. | |||
* '''[[Virological failure]]''' – The inability to suppress or reduce viral load despite treatment, often indicating drug resistance. | |||
* '''[[Virological.org]]''' – An online forum and repository for open scientific discussion about emerging viral threats and genome data. | |||
* '''[[Virology Journal]]''' – A peer-reviewed scientific journal covering all aspects of virology. | |||
* '''[[Virome]]''' – The total collection of viruses in a particular environment or organism. | |||
* '''[[Viropexis]]''' – A proposed mechanism of virus entry involving direct passage through the host cell membrane. | |||
* '''[[Virophysics]]''' – An interdisciplinary field applying principles of physics to understand viral assembly, entry, and dynamics. | |||
* '''[[Viroplasm]]''' – A specialized compartment within infected cells where viral replication and assembly occur. | |||
* '''[[Virus crystallisation]]''' – The process of purifying and crystallizing virus particles for structural analysis. | |||
* '''[[Virus inactivation]]''' – The process of destroying a virus’s infectivity using heat, chemicals, or radiation. | |||
* '''[[Virus latency]]''' – The state where a virus persists in a host cell without actively replicating, but can reactivate later. | |||
* '''[[Virus quantification]]''' – The measurement of viral concentration using techniques like [[plaque assay]], PCR, or ELISA. | |||
* '''[[Virusoid]]''' – A type of [[satellite RNA]] dependent on a helper virus for replication, often circular and non-coding. | |||
* '''[[Von Magnus phenomenon]]''' – The production of defective interfering viral particles during high-multiplicity passages. | |||
* '''[[Vpx]]''' – A viral accessory protein encoded by [[HIV-2]] and some [[SIVs]] that counteracts host restriction factors. | |||
* '''[[Zygotic induction]]''' – The activation of prophage genes in bacteria following [[conjugation]]. | |||
==See also== | ==See also== | ||
*[[Glossary of biology]] | *[[Glossary of biology]] | ||
*[[Glossary of genetics]] | *[[Glossary of genetics]] | ||
Latest revision as of 17:00, 29 March 2025
This glossary of virology is a list of definitions of terms and concepts used in the study of virology, particularly in the description of viruses and their actions. Table of contents: .A | .B | .C | .D | .E | .F | .G | .H | .I | .J | .K | .L | .M | .N | .O | .P | .Q | .R | .S | .T | .U | .V | .W | .X | .Y | .Z
Glossary of Virology[edit]
- AHL-1 cells – A human cell line used in virology studies, particularly for hepatitis and oncogenic virus research.
- Accessory gene regulator – A quorum sensing system in some bacteria and viruses that modulates gene expression, particularly in pathogenesis.
- Antigenic drift – A process of gradual accumulation of mutations in viral antigens, leading to changes in viral surface proteins and reduced immune recognition.
- Antigenic shift – A sudden, major change in a virus’s genome, especially in influenza viruses, resulting in a novel subtype to which most humans lack immunity.
- Attenuated vaccine – A vaccine created using a weakened form of a virus that is still capable of replication but not causing disease.
- Autogenous vaccines – Vaccines made from pathogens isolated from the same individual or herd for targeted treatment.
- Autoinoculation – The process by which an individual spreads a viral infection to different parts of their body.
- B type inclusion – Cytoplasmic inclusion bodies often found in cells infected with poxviruses.
- BCP-1 cells – A human B-cell line used in studies of Kaposi’s sarcoma-associated herpesvirus and other gammaherpesviruses.
- Baby hamster kidney cell – A widely used mammalian cell line (BHK-21) for culturing animal viruses and vaccine production.
- Baltimore classification – A system that classifies viruses based on their type of genome (DNA or RNA, single- or double-stranded) and replication strategy.
- Branched DNA assay – A signal amplification nucleic acid test used for detecting and quantifying viral RNA or DNA.
- Cap snatching – A mechanism used by some RNA viruses to "steal" 5’ caps from host mRNAs to initiate viral mRNA synthesis.
- Capsid – The protein shell of a virus that encloses its genetic material.
- Capsomere – The subunit of a capsid, formed by protein molecules.
- Cell-based vaccine – A type of vaccine developed using cultured cells instead of fertilized chicken eggs, commonly used for influenza.
- Coinfection – The simultaneous infection of a host by two or more virus strains or different pathogens.
- Common Cold Unit – A former UK-based research facility dedicated to studying respiratory viruses, especially the common cold.
- Cryspovirus – A genus of viruses that infect protozoa like Cryptosporidium.
- DNA vaccine – A vaccine that uses a plasmid containing viral DNA to elicit an immune response.
- DNA virus – A virus that has DNA as its genetic material and replicates using DNA-dependent DNA polymerase.
- DPVweb – A curated database of plant viruses and their properties.
- Decoy cells – Cells in the urine resembling virally infected urothelial cells, typically associated with polyomavirus infection.
- Duck embryo vaccine – A vaccine produced using duck embryos, historically used for rabies and other zoonotic viruses.
- Ecotropism – The tendency of certain viruses to infect only specific species or cell types.
- Embryonated – Refers to fertilized chicken eggs used to culture and propagate viruses, especially for vaccine production.
- Emergent virus – A newly identified virus that has recently appeared in a population or is rapidly increasing in incidence.
- Endogenous viral element – Viral sequences that have integrated into the host genome over evolutionary time.
- Endothelial cell tropism – The preference of certain viruses to infect the endothelial cells lining blood vessels.
- GISAID – The Global Initiative on Sharing All Influenza Data, a platform for sharing genome sequences of flu and emerging viruses like SARS-CoV-2.
- Gain-of-function research – Studies involving the enhancement of viral properties, such as transmissibility or pathogenicity, for scientific purposes.
- Global Virome Project – A collaborative effort to discover and catalog unknown viruses with potential pandemic risk.
- Global Virus Network (GVN) – A coalition of medical virologists working to prevent and control viral diseases through global research.
- Glossary of virology – A compiled list of terms and definitions commonly used in the field of virology.
- Group-specific antigen – Viral antigens specific to a group of viruses, used for diagnosis or vaccine design.
- HIV capsid inhibition – A therapeutic strategy that targets the capsid protein of HIV to inhibit viral replication.
- HIV latency – The ability of Human Immunodeficiency Virus (HIV) to remain dormant in host cells, forming a major barrier to a cure.
- Helper dependent virus – A virus that requires the presence of a helper virus to replicate.
- Helper virus – A virus that assists another defective or satellite virus to complete its replication cycle.
- Heterophile antibody test – A diagnostic test for Epstein-Barr virus using cross-reactive antibodies.
- Host tropism – The specificity of a virus for infecting particular host species or cell types.
- Human Immunodeficiency Virus (HIV) – A retrovirus that causes AIDS by targeting CD4+ T cells in the human immune system.
- Inclusion bodies – Intracellular structures formed during viral replication, often used as markers of infection.
- Integrase – A viral enzyme used by retroviruses to insert their genome into the host DNA.
- Intrastructural help – An immunological phenomenon where preexisting immunity to one viral protein enhances responses to others.
- Intrinsic immunity – Innate defense mechanisms in host cells that restrict viral replication even before adaptive immune responses.
- Laboratory-acquired infection – Infections contracted by lab personnel due to accidental exposure to infectious viruses.
- Leaky scanning – A translational control mechanism where ribosomes bypass the first start codon and initiate translation downstream.
- Live virus reference strain – A well-characterized virus used as a standard in vaccine production or diagnostic testing.
- Lysogenic cycle – A viral life cycle in which the genome is integrated into the host cell’s DNA and replicates passively without immediate destruction.
- Lytic cycle – A viral replication cycle that leads to the production of new viruses and host cell lysis.
- Multiplicity of infection – The ratio of infecting virus particles to target cells in an experimental setting.
- Neurovirology – The study of viruses that affect the nervous system and their interactions with neural cells.
- Nomenclature codes – Standardized rules used to name viruses and virus families as determined by bodies like the ICTV.
- Non-cellular life – Refers to entities like viruses and viroids that do not consist of cells but possess life-like properties.
- Oncovirus – A virus capable of causing cancer in humans or animals, e.g., HPV or EBV.
- Original antigenic sin – The immune system’s tendency to preferentially use memory responses from a first exposure even after exposure to a new strain.
- Orphan virus – A virus identified in the absence of a known associated disease.
- Paleovirology – The study of ancient viruses and their interactions with hosts through the analysis of endogenous viral elements in genomes.
- Passenger virus – A virus detected in a host without evidence of disease or replication.
- Permissive cell – A host cell that allows complete replication of a virus.
- PhEVER – A database of viral and host evolutionary relationships.
- PhagesDB – A database of bacteriophages and related data, commonly used in phage research.
- Phenotype mixing – A process where progeny viruses acquire proteins from a different parental virus without genetic recombination.
- Phycodnaviridae – A family of large dsDNA viruses that infect algae.
- Plant virus – A virus that specifically infects plants, often spread by insect vectors or through mechanical means.
- Plaque-forming unit – A measure of infectious virus particles, defined as one infectious unit that forms a visible plaque on a cell monolayer.
- Pleomorphism (microbiology) – The variability in shape and size among virus particles of the same species.
- Portal:Viruses – A central hub for accessing Wikipedia articles and resources related to virology and viruses.
- Pre-integration complex – A nucleoprotein structure formed by retroviruses after entry, containing viral DNA and enzymes like integrase for integration into the host genome.
- Prophage – A dormant form of a bacteriophage genome integrated into a bacterial chromosome during the lysogenic cycle.
- Provirus – Viral DNA that is integrated into the genome of a host cell, particularly in the context of retroviruses like HIV.
- Pseudodiploid – Describes cells (such as HIV particles) that carry two RNA genomes but replicate like diploids without true recombination.
- Pseudotyping – The process of producing recombinant viral particles that bear surface proteins (envelope) from a different virus, used in gene therapy and vaccine development.
- Q-number – A quality control identifier used in standardized virology tests and publications.
- Quasispecies model – A concept describing viral populations as dynamic, highly diverse groups of mutants around a consensus sequence, particularly in RNA viruses.
- RNA interference – A cellular defense mechanism that degrades viral RNA, used in research and therapy to silence gene expression.
- RNA virus – A virus that uses RNA as its genetic material; includes positive-sense, negative-sense, and double-stranded RNA viruses.
- Reassortment – The exchange of genome segments between different viral strains during coinfection, common in segmented RNA viruses like influenza.
- Recombinant virus – A genetically engineered virus containing genes from multiple sources, used in vaccine design and gene therapy.
- Reporter virus particles – Viruses modified to include a reporter gene, allowing detection of infection or replication by a visible signal.
- Satellite (biology) – A subviral agent that requires a helper virus for replication, often dependent on the capsid proteins of the helper.
- See virion – Refers to the complete infectious viral particle, see virion.
- Sense (molecular biology) – Refers to the orientation of RNA in terms of its coding potential: positive-sense or negative-sense RNA.
- Serial passage – A method of virus attenuation or adaptation by repeatedly infecting new hosts or cell cultures.
- Serratus (virology) – A cloud-based platform for the ultra-fast alignment and classification of RNA viruses in metagenomic data.
- Slow virus – A virus that causes disease after a prolonged incubation period, such as prions or lentiviruses.
- Spike protein – A surface glycoprotein that mediates viral entry by binding to host cell receptors; a key target in SARS-CoV-2 vaccine development.
- Strain (biology) – A genetic variant or subtype of a virus, often with specific phenotypic characteristics.
- Superinfection – Infection by a second virus in a host already infected with another, potentially altering disease outcome.
- Szybalski's rule – A rule stating that in double-stranded DNA, the non-template strand tends to be richer in guanine.
- T-number – A value describing the complexity of icosahedral virus capsid symmetry in terms of triangular facets.
- TRIM5alpha – A host protein that inhibits retroviral replication by blocking uncoating of the viral capsid.
- Temperateness (virology) – Describes viruses capable of entering both lytic and lysogenic cycles.
- The Last Days of Smallpox – A documentary about the final eradication efforts for smallpox, a landmark in virological history.
- Tissue tropism – The preference of a virus for infecting specific tissues or organs within a host.
- Transduction (genetics) – The process by which foreign DNA is introduced into a cell by a bacteriophage.
- Vaccine shedding – The release of vaccine virus from a vaccinated individual, usually associated with live attenuated vaccines.
- Vaccine trial – A clinical study designed to evaluate the safety, efficacy, and immunogenicity of a vaccine candidate.
- Vaccine – A preparation that stimulates the immune system to prevent disease, often containing inactivated or attenuated viruses.
- Variant (biology) – A version of a virus with genetic differences from a reference strain, potentially altering transmissibility or immune response.
- VirCapSeq – A high-throughput method for capturing and sequencing viral genomes from complex samples.
- Viral culture – The process of growing viruses in cell lines or tissues to study replication, pathogenesis, or for vaccine production.
- Viral dynamics – The quantitative study of how viruses replicate, spread, and interact with host immune responses over time.
- Viral entry – The process by which viruses penetrate host cells, involving attachment, fusion, or endocytosis.
- Viral envelope – A lipid bilayer derived from the host membrane, enclosing some viruses and aiding in host cell entry.
- Viral epitranscriptome – Modifications to viral RNA that regulate its stability, translation, or interaction with host defenses.
- Viral eukaryogenesis – The hypothesis that viruses may have played a role in the origin of the eukaryotic cell nucleus.
- Viral evolution – The genetic changes in virus populations over time due to mutation, selection, recombination, and drift.
- Viral interference – The phenomenon where one virus prevents the replication of another virus in the same host cell.
- Viral load – The amount of viral RNA or DNA in a host's body, often used as a marker of infection severity.
- Viral matrix protein – A structural protein located between the capsid and envelope, critical for viral assembly and budding.
- Viral metagenomics – The study of viral diversity and abundance in environmental or clinical samples using genome sequencing.
- Viral neuronal tracing – A method using viruses to map neural circuits by tracing connections between neurons.
- Viral pathogenesis – The process by which viruses cause disease in a host organism.
- Viral phylodynamics – The integration of viral evolution with epidemiological and immunological dynamics.
- Viral plaque – A clear area on a cell monolayer caused by virus-induced cell lysis, used to quantify infectious virus particles.
- Viral protein – Any protein encoded by a virus, often involved in replication, immune evasion, or structural integrity.
- Viral quasispecies – A group of closely related viruses within a host that exist as a mutant cloud, typical of RNA viruses.
- Viral replication – The process by which a virus reproduces inside a host cell, involving genome synthesis and particle assembly.
- Viral shedding – The release of virus particles from an infected host through respiratory droplets, feces, or other means.
- Viral synapse – A structured interface between infected and uninfected cells that facilitates efficient virus transfer.
- Viral tegument – A protein layer between the capsid and envelope in herpesviruses, involved in early infection steps.
- Viral transformation – The process by which viruses cause permanent genetic changes in a host cell, potentially leading to oncogenesis.
- ViralZone – An online database offering curated information on viral families, structure, replication, and classification.
- Viremia – The presence of viruses in the bloodstream, an indicator of systemic infection.
- Virion – The complete, infectious form of a virus, consisting of the genome, capsid, and, in some cases, an envelope.
- Viroinformatics – The application of bioinformatics tools to virology, including genome annotation and vaccine design.
- Virokine – A viral protein that mimics host cytokines, used by viruses to modulate the immune system.
- Virological failure – The inability to suppress or reduce viral load despite treatment, often indicating drug resistance.
- Virological.org – An online forum and repository for open scientific discussion about emerging viral threats and genome data.
- Virology Journal – A peer-reviewed scientific journal covering all aspects of virology.
- Virome – The total collection of viruses in a particular environment or organism.
- Viropexis – A proposed mechanism of virus entry involving direct passage through the host cell membrane.
- Virophysics – An interdisciplinary field applying principles of physics to understand viral assembly, entry, and dynamics.
- Viroplasm – A specialized compartment within infected cells where viral replication and assembly occur.
- Virus crystallisation – The process of purifying and crystallizing virus particles for structural analysis.
- Virus inactivation – The process of destroying a virus’s infectivity using heat, chemicals, or radiation.
- Virus latency – The state where a virus persists in a host cell without actively replicating, but can reactivate later.
- Virus quantification – The measurement of viral concentration using techniques like plaque assay, PCR, or ELISA.
- Virusoid – A type of satellite RNA dependent on a helper virus for replication, often circular and non-coding.
- Von Magnus phenomenon – The production of defective interfering viral particles during high-multiplicity passages.
- Vpx – A viral accessory protein encoded by HIV-2 and some SIVs that counteracts host restriction factors.
- Zygotic induction – The activation of prophage genes in bacteria following conjugation.
See also[edit]
- Glossary of biology
- Glossary of genetics
- Glossary of scientific naming
- Introduction to viruses
- List of viruses
| Microbiology: Virus | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|